Skip to content

Clinical trials

Completed Generalized Anxiety Disorder trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Status: Completed Country / region: Canada Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20064
20082
20101
20123
20132
20141
20152
20162
20172
20182
20193
20202
20212
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health4
AstraZeneca2
Concordia University, Montreal2
Dr. Nazanin Alavi2
Toronto Metropolitan University2
Universite du Quebec en Outaouais2
Eli Lilly and Company1
John Papastergiou Pharmacy Ltd1
Kinesis Health Associates1
Laval University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder32
Anxiety Disorders18
Phobia, Social7
Major Depressive Disorder6
Panic Disorder6
Agoraphobia4
Dysthymic Disorder2
Stress Disorders, Post-Traumatic2
Attention Deficit Disorder with Hyperactivity1
Chronic Pain1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.